Renata Limited (officially Renata PLC), formerly known as Pfizer Laboratories (Bangladesh) Limited, is a publicly traded pharmaceutical company headquartered in Mirpur, Dhaka, Bangladesh. It is one of the top ten pharmaceutical manufacturers in Bangladesh by revenue.
Overview
Renata Limited is engaged in the manufacture and marketing of human pharmaceutical products and animal health products, including animal therapeutics and nutrition products. The company was originally established in 1972 as Pfizer (Bangladesh) Limited. In 1993, following a change in ownership and name, it became Renata Limited. The company is listed on the Dhaka Stock Exchange under the ticker symbol RENATA.
Operations
As of 2024, Renata employs approximately 11,000 people. Its head office is located in Mirpur, Dhaka, and it operates 14 production facilities across Mirpur, Dhaka, Rajendrapur, Gazipur, and Bhaluka, Mymensingh. The company's potent product facility has received UK MHRA approval and exports prednisolone to the United Kingdom. In April 2024, Renata began directly exporting medicines to the United States.
Products
Renata manufactures a range of pharmaceutical and animal health products, including brands such as Maxpro, Rolac, Fenadin, Rolip, and Furoclav.
Partnerships
The Global Alliance for Improved Nutrition (GAIN) provided US$2.9 million to Renata Limited and BRAC to develop a business model for producing and delivering multi-nutrient powders to vulnerable infants in Bangladesh.
Controversy
In January 2016, Renata was fined by the Bangladesh Department of Environment for alleged environmental damage, though the claim was not finally proven. Additional unproven allegations have been made regarding illegal occupation of forest department land and land grabbing by the company's CEO, Syed S. Kaiser Kabir.
Key People
- CEO: Syed S. Kaiser Kabir
External Links
- Official website: renata-ltd.com
